2U3:FRA
Alcon AG
56,10 €
arrow_downward
-0,04%(-0,020) 1D
7 tet, 10:00:00 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 2U3...
Hap
55,86 €
I lartë
56,20 €
I ulët
55,86 €
Kapitalizimi i tregut
26,62Â mld
Vëllimi mesatar
135,00
Vëllimi
45,00
Maksimumi 52-javor
73,96 €
Minimumi 52-javor
51,78 €
Numri i punonjësve
25 mijë
Hap
55,86 €
I lartë
56,20 €
I ulët
55,86 €
Kapitalizimi i tregut
26,62Â mld
Vëllimi mesatar
135,00
Vëllimi
45,00
Maksimumi 52-javor
73,96 €
Minimumi 52-javor
51,78 €
Numri i punonjësve
25 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
6 orë më parë
EUR 56.57 at Lang & Schwarz: Alcon stock after-hours plus 0.86 percent versus the prior close
AD HOC NEWS
·
11 orë më parë
Alcon stock trades at CHF 52.90 before November 10 earnings
AD HOC NEWS
·
1 ditë më parë
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
2 ditë më parë
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profili
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Rreth Alcon AG
Drejtori ekzekutivDavid J. Endicott
Punonjësit25 mijë
Themeluar më1945
SeliaGjeneva, Kantoni Gjenevë, Zvicër
SektoriMedical device
Uebsajtialcon.com